| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 28-Sep-07 | | Total Revenue | 1,172,000 | 1,076,600 | 1,090,600 | 973,700 | | Cost of Revenue | 197,500 | 182,200 | 179,800 | 159,500 | | | Gross Profit | 974,500 | 894,400 | 910,800 | 814,200 | | | Operating Expenses | | Research Development | 213,400 | 182,900 | 189,700 | 162,700 | | Selling General and Administrative | 506,900 | 482,200 | 465,000 | 387,900 | | Non Recurring | 9,400 | 28,400 | 2,500 | 11,000 | | Others | 35,800 | 34,900 | 35,200 | 28,700 | | | | Total Operating Expenses | 765,500 | 728,400 | 692,400 | 590,300 | | | | Operating Income or Loss | 209,000 | 166,000 | 218,400 | 223,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,900 | 5,000 | 8,300 | 8,300 | | Earnings Before Interest And Taxes | 210,900 | 171,000 | 226,700 | 232,200 | | Interest Expense | 14,800 | 15,400 | 17,900 | 17,500 | | Income Before Tax | 196,100 | 155,600 | 208,800 | 214,700 | | Income Tax Expense | 48,400 | 44,000 | 47,500 | 56,500 | | Minority Interest | (400) | (200) | (100) |
-
| | | | Net Income From Continuing Ops | 147,300 | 111,400 | 161,200 | 158,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (900) | (800) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 147,300 | 111,400 | 160,300 | 157,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $147,300 | $111,400 | $160,300 | $157,400 |
|
2.99% Nasdaq 
Income Statement
